207_Combined course Presentations



757 oligometastatic patients Training and validation cohorts Surgery to primary tumors: 83.9% Surgery to metastatic patients: 62.3%

RPA OVERALL SURVIVAL







47.8%

13.8%

Ashworth A et al, Clin Lung Cancer 2014;15